888 related articles for article (PubMed ID: 18286613)
81. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
[TBL] [Abstract][Full Text] [Related]
82. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation.
Evan AP; Worcester EM; Williams JC; Sommer AJ; Lingeman JE; Phillips CL; Coe FL
Anat Rec (Hoboken); 2015 May; 298(5):865-77. PubMed ID: 25615853
[TBL] [Abstract][Full Text] [Related]
83. [Calcium oxalate stone formation. New pathogenetic aspects of an old disease].
Wendt-Nordahl G; Evan AP; Spahn M; Knoll T
Urologe A; 2008 May; 47(5):538, 540-44. PubMed ID: 18392604
[TBL] [Abstract][Full Text] [Related]
84. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
[No Abstract] [Full Text] [Related]
85. Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation.
Lyons Ryall R; Fleming DE; Doyle IR; Evans NA; Dean CJ; Marshall VR
J Struct Biol; 2001 Apr; 134(1):5-14. PubMed ID: 11469872
[TBL] [Abstract][Full Text] [Related]
86. Low specific gravity urine with crystalluria as discriminant index for nephrolithiasis.
Sriboonlue P; Prasongwattana V; Sriboonlue M; Chata K; Tungsanga K; Sitprija V
J Med Assoc Thai; 1990 Nov; 73(11):634-40. PubMed ID: 2283493
[TBL] [Abstract][Full Text] [Related]
87. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
Laube N; Schmidt M; Hesse A
Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
[TBL] [Abstract][Full Text] [Related]
88. [Respective effect of calcium and oxalate on calcium oxalate crystallization in the urine].
Berland Y; Olmer M; Boistelle R; Barlatier A
Nephrologie; 1984; 5(4):175-9. PubMed ID: 6527720
[TBL] [Abstract][Full Text] [Related]
89. Studies on structure of calcium oxalate monohydrate renal papillary calculi. Mechanism of formation.
Grases F; Costa-Bauzá A; Conte A
Scanning Microsc; 1993 Sep; 7(3):1067-73; discussion 1073-4. PubMed ID: 8146607
[TBL] [Abstract][Full Text] [Related]
90. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
Kavanagh JP; Laube N
J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
[TBL] [Abstract][Full Text] [Related]
91. Microstructure of decalcified human calcium oxalate urinary stones.
Khan SR; Hackett RL
Scan Electron Microsc; 1984; (Pt 2):935-41. PubMed ID: 6385225
[TBL] [Abstract][Full Text] [Related]
92. [New pathophysiologic aspects of nephrolithiasis].
Hess B
Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
[TBL] [Abstract][Full Text] [Related]
93. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
[TBL] [Abstract][Full Text] [Related]
94. Calcium oxalate calculi found attached to the renal papilla: Preliminary evidence for early mechanisms in stone formation.
Williams JC; Matlaga BR; Kim SC; Jackson ME; Sommer AJ; McAteer JA; Lingeman JE; Evan AP
J Endourol; 2006 Nov; 20(11):885-90. PubMed ID: 17144856
[TBL] [Abstract][Full Text] [Related]
95. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
[TBL] [Abstract][Full Text] [Related]
96. [Plasma oxalate concentration in calcium oxalate stone formers].
Hoshina A
Hinyokika Kiyo; 1984 Oct; 30(10):1405-15. PubMed ID: 6524552
[TBL] [Abstract][Full Text] [Related]
97. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
[TBL] [Abstract][Full Text] [Related]
98. Characteristics of renal papillae in kidney stone formers.
Marien TP; Miller NL
Minerva Urol Nefrol; 2016 Dec; 68(6):496-515. PubMed ID: 27441596
[TBL] [Abstract][Full Text] [Related]
99. Calcium oxalate crystals in human pathology. Molecular analysis with the laser Raman microprobe.
Pestaner JP; Mullick FG; Johnson FB; Centeno JA
Arch Pathol Lab Med; 1996 Jun; 120(6):537-40. PubMed ID: 8651854
[TBL] [Abstract][Full Text] [Related]
100. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
Singh P; Enders FT; Vaughan LE; Bergstralh EJ; Knoedler JJ; Krambeck AE; Lieske JC; Rule AD
Mayo Clin Proc; 2015 Oct; 90(10):1356-65. PubMed ID: 26349951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
